[Clinical efficacy of NovaSure for 30 patients with adenomyosis].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 41(1): 88-92, 2016 Jan.
Article
em Zh
| MEDLINE
| ID: mdl-26819431
ABSTRACT
OBJECTIVE:
To investigate the efficacy and safety of NovaSure system for dysmenorrhea and abnormal uterine bleeding of adenomyosis.â©METHODS:
A retrospective analysis on 30 patients with adenomyosis, who treated by NovaSure, were carried out. We collected related clinical data before operation and collected postoperative information about dyemenorrhea, menstruation, anemia and uterine volume by visiting outpatient or telephone.â©RESULTS:
All patients were followed up for 7 to 31 months after the operation. The relief rate of menstrual pain was 83.3%. All patients got obvious improvements in menstruation and anemia (P<0.05). After operation, uterine volume was significantly decreased (P<0.05). Only one case received intervention in 2 years (3.3%).â©CONCLUSION:
NovaSure can relieve symptoms of menorrhagia and alleviate dysmenorrhea symptoms. It is a new way for the treatment of uterine adenomyosis.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Dismenorreia
/
Técnicas de Ablação Endometrial
/
Adenomiose
/
Menorragia
Tipo de estudo:
Observational_studies
Limite:
Female
/
Humans
Idioma:
Zh
Revista:
Zhong Nan Da Xue Xue Bao Yi Xue Ban
Assunto da revista:
MEDICINA
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
China